TIEFENBACHER PHARMACEUTICALS: Product Portfolio
Generic, value added, and innovative products including highly potent drugs for patients worldwide
Tiefenbacher Pharmaceuticals: Everything from a single source and tailored to your needs. Gain access to novel products (FDF + highly potent drugs), speed up time-to-market and open up unexplored business avenues. We are developing high-quality pharmaceuticals with a patients-centered approach adapted for each market worldwide.
We have successfully developed and marketed a range of products, many of which are leaders in their respective markets. We provide over 180+ products across various therapeutic categories in 10+ dosage forms including highly potent drugs and drug medical device combinations. Value added medicines (VAM) and innovative formulations form an important part of our portfolio – Whether it´s fewer side effects, a better API absorption or a personalized drug dispensing device, we at Tiefenbacher Pharmaceuticals believe that there are always new ways of smart medicines which better deliver on patients´ needs. Please have a look at our portfolio of products that we have available for out-licensing.
| Product | Brand (RLD) | Therapeutical Group | ATC-Indication | Pharmaceutical Form | Strength | Under Development | Under Registration | Available |
|---|---|---|---|---|---|---|---|---|
| Alectinib (IN-HOUSE) | Alecensa® | Antineoplastic and Immunomodulating Agents | L01E Protein Kinase Inhibitors | Capsule | 150mg* *(Zone IVb) | Under Development | ||
| Alitretinoin (IN-HOUSE) | Toctino® | Dermatologicals | D11A other dermatological agents for dermatitis excl. corticosteroids | Capsule | 10mg 30mg | Under Development | ||
| Bilastine | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Oral Solution | 10mg/4ml* *(Zone IVb) | Under Development | ||
| Darolutamide (IN-HOUSE) | Nubeqa® | Antineoplastic and Immunomodulating Agents | L02B Hormone Antagonists And Related Agents | Film-coated tablet | 300mg* *(Zone IVb) | Under Development | ||
| Levamlodipine (except US) | Conjupri® | Cardiovascular System | C08C Selective calcium channel blockers with mainly vascular effects | Tablet | 2,5mg 5mg | Under Development | ||
| Lithium XR (IN-HOUSE) | Quilonum® | Nervous System | N05AN Psycholeptics bipolar disorders major depression cluster headache | Extended Release tablet | 300mg* 450mg* 625mg* *(Zone IVb) | Under Development | ||
| Macitentan+Tadalafil | Opsynvi® | Cardiovascular System | C02KX54 Other antihypertensives (Pulmonary, Arterial Hypertension) | Tablet | 10mg+40mg | Under Development | ||
| Mercaptamine (IN-HOUSE) | Procysbi ® | Alimentary Tract and Metabolism | A16A Other alimentary tract and metabolism products (Cystinosis) | Capsule and stick pack | 25mg* cap. 75mg* cap. 75mg* stick packs 300mg* stick packs | Under Development | ||
| Neratinib (IN-HOUSE) | Nerlynx® | Antineoplastic drugs | L01E Antineoplastic drug (early-stage hormone receptor positive HER2- overexpressed/amplified breast cancer) | Film-coated tablet | 40mg* 120mg* *(Zone IVb) | Under Development | ||
| Netupitant+ Palonosetron (IN-HOUSE) | Akynzeo® | Antineoplastic and Immunomodulating Agents | A04AA Serotonin antagonists | Tablet | 300mg+0.5mg* *(Zone IVb) | Under Development | ||
| Niraparib (IN-HOUSE) | Zejula® | Antineoplastic and Immunomodulating Agents | L01X other antineoplastic drugs 2nd line ovarian cancer | Tablet | 100mg* 200mg* 300mg* *(Zone IVb) | Under Development | ||
| Olaparib | Lynparza® | Antineoplastic and Immunomodulating Agents | L01X Cancer Ovarian, Breast, Prostate, Pancreas | Film-coated tablet | 100mg* 150mg* *(Zone IVb) | Under Development | ||
| Pitolisant (IN-HOUSE) | Wakix® Ozawade® | Nervous system | N07X treatment of narcolepsy with or without cataplexy | Tablet | 4,5mg* 18mg* *(Zone IVb) | Under Development | ||
| Ponatinib | Iclusig® | Antineoplastic and Immunomodulating Agents | L01E chronic myelogenous leukaemia (CML) | Tablet | 15mg 30mg 45mg | Under Development | ||
| Posaconazol (IN-HOUSE) | Noxafil® | Antiinfectives For Systemic Use | J02A Antimycotics for systemic use (Antifungal) | Gastro-resistant tablet | 300mg* *(Zone IVb) | Under Development | ||
| Regorafenib (IN-HOUSE) | Stivarga® | Antineoplastic and Immunomodulating Agents | L01E Protein kinase inhibitor colorectal cancer gastrointestinal stromal tumors hepatocellular carcinoma | Tablet | 40mg* 160mg* *(Zone IVb) | Under Development | ||
| Trientine (IN-HOUSE) | Cuprior™ | Alimentary Tract and Metabolism | A16A Other Alimentary Tract And Metabolism Products | Film-coated tablet | 75mg* 150mg* *(Zone IVb) | Under Development | ||
| Vismodegib (IN-HOUSE) | Erivedge® | Antineoplastic and Immunomodulating Agents | L01XJ01 Hedgehog pathway inhibitors | Capsule | 150mg* *(Zone IVb) | Under Development | ||
| Venetoclax (IN-HOUSE) | Venclexta®/ Venclyxto® | Antineoplastic and Immunomodulating Agents | L01X Other antineoplastic agents (Chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML)) | Film-coated tablet | 10mg 50mg 100mg* *(Zone IVb) | Under Development | ||
| Apremilast (IN-HOUSE) | Otezla® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Psoriasis and psoriatic arthritis) | Film-coated tablet | 10mg 20mg 30mg | Under Registration | 1 | |
| Butylscopolamin+ Paracetamol (IN-HOUSE) | Buscopan PLUS® | Alimentary Tract and Metabolism | A03B Belladonna and derivatives, plain (Spasmolytic) | Film-coated tablet | 10mg+500mg* | Under Registration | 1 | |
| Edoxaban (IN-HOUSE) | Lixiana® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke) | Film-coated tablet | 15mg* 30mg* 60mg* *(Zone IVb) | Under Registration | 1 | |
| Ibuprofen+ Caffeine | Thomapyrin Tension Duo® | Musculo-Skeletal System | M01A Antiinflammatory And Antirheumatic Products, Non-Steroids | Sachet | 400mg+100mg* *(Zone IVb) | Under Registration | 1 | |
| Macitentan US | Opsumit® | Cardiovascular System | C02K Other antihypertensives (Pulmonary, Arterial Hypertension) | Film-coated tablet | 10mg* *(Zone IVb) | Under Registration | 1 | |
| Minoxidil | Lonolox® | Cardiovascular System | C02DC01 Therapy resistant hypertension | Tablet | 2,5 mg 5 mg 10 mg | Under Registration | 1 | |
| Nalmefene | Selincro® | Nervous System | N07B Alcohol-Related Disorders | Film-coated tablet | 18mg* *(Zone IVb) | Under Registration | 1 | |
| Rivaroxaban+ Acetylic Acid (IN-HOUSE) | Blood and Blood Forming Organs | B01A Antithrombotic agents (Coronary Syndroms, Coronary Artery Disease, Symtomatic Peripheral Arterial Disease | Film-coated tablet Combi blister | 2,5mg+100mg* *(Zone IVb) | Under Registration | 1 | ||
| Sacubitril+ Valsartan EU (IN-HOUSE) | Entresto® | Cardiovascular System | C09D Angiotensin II receptor blockers (ARBs), plain (Chronic Heart Failure) | Film-coated tablet | 24mg+26mg* 49mg+51mg* 97mg+103mg* *(Zone IVb) | Under Registration | 1 | |
| Safinamide (IN-HOUSE) | Xadago® | Nervous system | N04B Parkinson disease | Film-coated tablet | 50mg* 100mg* *(Zone IVb) | Under Registration | 1 | |
| Abiraterone | Zytiga® | Antineoplastic and Immunomodulating Agents | L02B Hormone antagonists and related agents (Prostatic Neoplasms) | Tablet, Film-coated tablet | 250mg* 500mg* *(Zone IVb) | Available | ||
| Abiraterone + Prednisolone | Abiraterone: Zytiga® Prednisolone: Pfizer® | Antineoplastic and Immunomodulating Agents | L02B Hormone antagonists and related agents (Prostatic Neoplasms) | Film-coated tablet | 500mg+5mg 500mg+10mg | Available | ||
| Ambrisentan (IN-HOUSE) | Volibris® | Cardiovascular System | C02K Other antihypertensives (Pulmonary, Arterial Hypertension) | Film-coated tablet | 5mg* 10mg* *(Zone IVb) | Available | ||
| Amifampridine (IN-HOUSE) | Firdapse® | Nervous System | N07X Other nervous system drugs (Lambert-Eaton Myasthenic Syndrome) | Tablet | 10mg | Available | ||
| Apixaban | Eliquis® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Tablet | 2.5mg, 5mg | Available | ||
| Arsenic trioxide | Trisenox® | Antineoplastic and Immunomodulating Agents | L01XX27 Induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) | vial | 1 mg/ml | Available | ||
| Atorvastatin+ Ezetimibe | Atozet® | Cardiovascular System | C10B Lipid modifying agents, combinations (Hyperlipidemia) | Film-coated tablet | 10mg+10mg 20mg+10mg 40mg+10mg 80mg+10mg | Available | ||
| Bilastine | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Tablet | 20mg* *(Zone IVb) | Available | ||
| Bilastine ODT | Bilaxten® | Respiratory System | R06A Antihistamines for systemic use | Orodispersible tablet | 10mg 20mg* *(Zone IVb) | Available | ||
| Bimatoprost | Lumigan® | Sensory Organs | S01E Antiglaucoma | Solution | 0.1mg/ml 0.3mg/ml | Available | ||
| Bimatoprost+ Timolol | Ganfort® | Sensory Organs | S01E Antiglaucoma | Solution | 0.3mg/ml+5mg/ml | Available | ||
| Brimonidine | Alphagan® | Sensory Organs | S01G Decongestants and antiallergics | Solution | 2mg/ml | Available | ||
| Brimonidine+ Timolol | Combigan® | Sensory Organs | S01G Decongestants and antiallergics | Solution | 2mg+5mg/ml* | Available | ||
| Brivudine (IN-HOUSE) | Zostex® | Anti-infective for Systemic Use | J05A Antiviral (Herpes Zoster) | Tablet | 125mg* *(Zone IVb) | Available | ||
| Buprenorphine | Transtec PRO® | Nervous System | N02A Opioids (Analgesic Malignant Pain) | Transdermal patch | 35μg/h* 52.5μg/h 70μg/h* (4‐day patch) *(Zone IVb) | Available | ||
| Buprenorphine | Norspan® | Nervous System | N02A Opioids (Analgesic Non‐Malignant Pain) | Transdermal patch | 5μg/h 10μg/h 15μg/h 20μg/h (7‐day patch) | Available | ||
| Carvedilol (IN-HOUSE) | Dilatrend® | Cardiovascular System | C07A Beta blocking agents (Hypertension) | Film-coated tablet | 3.125mg 6.25mg 12.5mg 25mg | Available | ||
| Escitalopram (IN-HOUSE) | Cipralex® | Nervous System | N06A Antidepressants (Depression) | Film-coated tablet | 5mg 10mg 15mg 20mg* *(Zone IVb) | Available | ||
| Eslicarbazepin (IN-HOUSE) | Exalief®/ Zebinix® | Nervous System | N03A Antiepileptics (Epilepsy) | Tablet | 200mg* 400mg* 600mg* 800mg* *(Zone IVb) | Available | ||
| Eszopiclone | Lunesta®/ Eszop® | Nervous System | N05C Hypnotics and sedatives (Insomnia) | Film-coated tablet | 1mg 2mg 3mg | Available | ||
| Etoricoxib (IN-HOUSE) | Arcoxia® | Musculo-Skeletal System | M01A Antirheumatic | Film-coated tablet | 30mg* 60mg* 90mg* 120mg* *(Zone IVb) | Available | ||
| Fingolimod | Gilenya® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Multiple Sclerosis) | Capsule | 0.5mg* *(Zone IVb) | Available | ||
| Gabapentin | Neurontin® | Nervous System | N03A Antiepileptics (Epilepsy) | Capsule | 100mg 300mg 400mg | Available | ||
| Gabapentin | Neurontin® | Nervous System | N03A Antiepileptics (Epilepsy) | Film-coated tablet | 600mg 800mg | Available | ||
| Ivabradine (IN-HOUSE) | Procoralan® | Cardiovascular System | C01E Other cardiac preparations (Angina pectoris) | Film-coated tablet | 5mg* 7.5mg* *(Zone IVb) | Available | ||
| Lacosamide | Vimpat® | Nervous System | N03A Antiepileptics (Epilepsy) | Film-coated tablet | 50mg* 100mg* 150mg* 200mg* *(Zone IVb) | Available | ||
| Lamotrigine | Lamictal® | Nervous System | N03A Antiepileptics (Epilepsy, Depression) | Tablet | 25mg 50mg 100mg 200mg | Available | ||
| Latanoprost | Xalatan® | Sensory Organs | S01E Antiglaucoma | Solution | 50μg/ml | Available | ||
| Latanoprost+ Timolol | Xalacom® | Sensory Organs | S01E Antiglaucoma | Solution | 50μg/ml+5mg/ml | Available | ||
| Leflunomide | Arava® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Rheumatoid arthritis and psoriatic arthritis) | Film-coated tablet | 10mg 20mg* *(Zone IVb) | Available | ||
| Leflunomide | Arava® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Rheumatoid arthritis and psoriatic arthritis) | Film-coated tablet | 15mg* *(Zone IVb) | Available | ||
| Montelukast | Singulair® | Respiratory System | R03D Other systemic drugs for obstructive airway diseases | Chewable tablet | 4mg 5mg | Available | ||
| Montelukast | Singulair® | Respiratory System | R03D Other systemic drugs for obstructive airway diseases | Film-coated tablet | 10mg* *(Zone IVb) | Available | ||
| Pantoprazole (IN-HOUSE) | Pantozol® | Alimentary Tract and Metabolism | A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (Proton Pump Inhibitor) | Enteric‐coated tablet | 20mg* 40mg* *(Zone IVb) | Available | ||
| Pirfenidone | Intermune® | Antineoplastic and Immunomodulating Agents | L04AX05 Antineoplastic and immunmodulating agent | Film-coated tablet | 267mg 534mg 801mg | Available | ||
| Posaconazol (IN-HOUSE) | Noxafil® | Anti-infective for Systemic Use | J02A Antimycotics for systemic use (Antifungal) | Gastro-resistant tablet | 100mg* *(Zone IVb) | Available | ||
| Pravastatin | Pravasin® | Cardiovascular System | C10A Lipid modifying agents, plain (Cholesterol‐Lowering) | Film-coated tablet | 10mg 20mg 40mg | Available | ||
| Prucaloprid (IN-HOUSE) | Resolor® | Alimentary Tract and Metabolism | A06A Drugs for constipation | Film-coated tablet | 1mg* 2mg* *(Zone IVb) | Available | ||
| Quetiapine | Seroquel® | Nervous System | N05A Antipsychotics | Film-coated tablet | 25mg* 100mg* 150mg 200mg* 300mg* *(Zone IVb) | Available | ||
| Quinine Sulfate (IN-HOUSE) | Limptar® | Musculo-skeletal system | P01BC01, M09AA72 Muscle relaxant, antimalarial agent | Film-coated tablet | 200mg | Available | ||
| Rasagiline (IN-HOUSE) | Azilect® | Nervous System | N04B Dopaminergic agents (Parkinson) | Tablet | 1mg* *(Zone IVb) | Available | ||
| Rivaroxaban (IN-HOUSE) | Xarelto® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Film-coated tablet | 2.5mg 10mg* 15mg* 20mg* *(Zone IVb) | Available | ||
| Teriflunomide (IN-HOUSE) | Aubagio® | Antineoplastic and Immunomodulating Agents | L04A Immunosuppressants (Multiple Sclerosis) | Film-coated tablet | 7mg 14mg* *(Zone IVb) | Available | ||
| Ticagrelor (IN-HOUSE) | Brilique® | Blood and Blood Forming Organs | B01A Antithrombotic agents (Stroke, Heart Attack) | Film-coated tablet | 60mg* 90mg* *(Zone IVb) | Available | ||
| Varenicline Citrate (IN-HOUSE) | Champix® | Nervous System | N07B Drugs used in addictive disorders (Nicotine Dependents) | Film-coated tablet | 0.5mg* 1mg* *(Zone IVb) | Available | ||
| Vildagliptin | Galvus® | Alimentary Tract and Metabolism | A10B Blood glucose lowering drugs, excluding insulins (Diabetes Mellitus) | Tablet | 50mg* *(Zone IVb) | Available | ||
| Vildagliptin+ Metformin | Eucreas® | Alimentary Tract and Metabolism | A10B Blood glucose lowering drugs, excluding insulins (Diabetes Mellitus) | Film-coated tablet | (50mg+500mg*) 50mg+850mg* 50mg+1000mg* *(Zone IVb) | Available |
We are committed to providing better therapies for patients worldwide – we are happy to present you more about our differentiated and innovative pipeline in person.
We out-license ready-to-market finished products (FDF) across various therapeutic categories in 10+ dosage forms including highly potent drugs. Our goal is to offer a fast and flexible service following the highest quality standards that allows our customers to reduce market entry times. For more information about our differentiated and innovative product pipeline, please contact us – by filling out the contact form below on this webpage, or please send an email to info@tiefenbacher.com. We are looking forward to sharing out-licensing opportunities based on a CDA and the specific marketing & sales requirements worldwide.
Our Products: High quality generic, value added, and innovative medicines for global markets
Grow your brand with our healthcare solutions making pharmaceuticals more affordable, more available, and better than before
Tiefenbacher Pharmaceuticals is developing in-house products that address specific therapeutic needs in unique formulations of prescription drugs (Rx) as well as over-the-counter (OTC) medicines. Our products are always developed with the objective of providing the maximum benefits to the patient. We globally out-license ready-to-market finished products across various therapeutic categories in 10+ dosage forms – and additional drug medical devices combinations.
Our business approach is based on making pharmaceuticals more affordable, more available, and better than before. We are specialized in adjusting to specific local requirements and customer challenges to ensure that our solutions make a sustainable impact.
Diseases Areas
Oncology
Respiratory
Neuroscience
Cardiovascular, Renal, and Metabolism
Immunology, Hepatology, and Dermatology
Infectious Diseases
Ophthalmology
Dosages Forms
Tablets
Capsules
Powder
Drops
Inhaler
Transdermal Patches
Eye Drops
Additional
Medical Devices
We, at Tiefenbacher Pharmaceuticals, are making medicines more affordable, more available, and better than before. Do not hesitate to get in touch for more information about our differentiated and innovative product pipeline.Please contact us by filling out the contact form below and clicking “Send message”. Tiefenbacher Pharmaceuticals will follow up with you personally as soon as possible.
